Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability
VeraCept Phase III
Sponsor:Sebela Pharmaceuticals Development LLC
Enrolling:Female Patients Only
Clinic Visits:14
Age Range:Between 18 and 45 years old
IRB Number:AAAS0078
Contact: Connie Colon: 212-305-6098 /
Additional Study Information:

We are asking you to participate in this research study because you are a woman of child-bearing age or potential and interested in using an intrauterine device (IUD) for birth control for up to 5 years.

This study is closed
Carolyn Westhoff, MD
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Connie Colon
Phone: 212-305-6098